| Literature DB >> 24453358 |
Bert K Rima1, Derek Gatherer, Daniel F Young, Hanna Norsted, Richard E Randall, Andrew J Davison.
Abstract
UNLABELLED: The strain diversity of a rubulavirus, parainfluenza virus 5 (PIV5), was investigated by comparing 11 newly determined and 6 previously published genome sequences. These sequences represent 15 PIV5 strains, of which 6 were isolated from humans, 1 was from monkeys, 2 were from pigs, and 6 were from dogs. Strain diversity is remarkably low, regardless of host, year of isolation, or geographical origin; a total of 7.8% of nucleotides are variable, and the average pairwise difference between strains is 2.1%. Variation is distributed unevenly across the PIV5 genome, but no convincing evidence of selection for antibody-mediated evasion in hemagglutinin-neuraminidase was found. The finding that some canine and porcine, but not primate, strains are mutated in the SH gene, and do not produce SH, raised the possibility that dogs (or pigs) may not be the natural host of PIV5. The genetic stability of PIV5 was also demonstrated during serial passage of one strain (W3) in Vero cells at a high multiplicity of infection, under conditions of competition with large proportions of defective interfering genomes. A similar observation was made for a strain W3 mutant (PIV5VΔC) lacking V gene function, in which the dominant changes were related to pseudoreversion in this gene. The mutations detected in PIV5VΔC during pseudoreversion, and also those characterizing the SH gene in canine and porcine strains, predominantly involved U-to-C transitions. This suggests an important role for biased hypermutation via an adenosine deaminase, RNA-specific (ADAR)-like activity. IMPORTANCE: Here we report the sequence variation of 16 different isolates of parainfluenza virus 5 (PIV5) that were isolated from a number of species, including humans, monkeys, dogs, and pigs, over 4 decades. Surprisingly, strain diversity was remarkably low, regardless of host, year of isolation, or geographical origin. Variation was distributed unevenly across the PIV5 genome, but no convincing evidence of immune or host selection was found. This overall genome stability of PIV5 was also observed when the virus was grown in the laboratory, and the genome stayed remarkably constant even during the selection of virus mutants. Some of the canine isolates had lost their ability to encode one of the viral proteins, termed SH, suggesting that although PIV5 commonly infects dogs, dogs may not be the natural host for PIV5.Entities:
Mesh:
Year: 2014 PMID: 24453358 PMCID: PMC3993540 DOI: 10.1128/JVI.03351-13
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103
Information on the PIV5 genome sequences determined in this study (with read data) or deposited by others
| PIV5 strain | Host source | Country of origin | Decade of isolation | GenBank accession no. | No. of Illumina reads | % matching reads |
|---|---|---|---|---|---|---|
| MEL | Human | UK | 1970s | 2,711,800 | 92 | |
| MIL | Human | UK | 1970s | 2,452,893 | 88 | |
| DEN | Human | UK | 1970s | 2,222,620 | 89 | |
| LN | Human | UK | 1970s | 2,229,468 | 83 | |
| RQ | Human | UK | 1970s | 2,070,127 | 77 | |
| W3(cl) | Macaque | USA | 1960s | |||
| W3 | Macaque | USA | 1960s | 21,156,178 | 78 | |
| Cryptovirus | Human | USA | Not known | |||
| SER | Pig | Germany | 1990s | 1,634,295 | 71 | |
| KNU-11 | Pig | South Korea | 2010s | |||
| CPI+ | Dog | Germany | 1980s | 1,505,580 | 59 | |
| CPI− | Dog | Germany | 1980s | 1,441,355 | 64 | |
| 1168-1 | Dog | South Korea | 2000s | |||
| 78524 | Dog | UK | 1980s | 2,294,166 | 78 | |
| H221 | Dog | UK | 1980s | 2,251,985 | 86 | |
| 08-1990 | Dog | South Korea | 2000s | |||
| D277 | Dog | South Korea | 2000s |
Data from pairwise comparisons of complete PIV5 genome sequences
| Strain | No. of substitutions/nt site or ω value | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEL | MIL | DEN | LN | RQ | W3 | Crypto | SER | KNU-11 | CPI+ | CPI− | 1168-1 | 78524 | H221 | 08-1990 | D277 | |
| MEL | 0.99 | 0.13 | 0.13 | 0.20 | 0.22 | 0.13 | 0.14 | 0.12 | 0.10 | 0.11 | 0.13 | 0.13 | ||||
| MIL | 0.001 | 0.80 | 0.13 | 0.13 | 0.19 | 0.22 | 0.13 | 0.14 | 0.12 | 0.09 | 0.10 | 0.13 | 0.13 | |||
| DEN | 0.001 | 0.001 | 0.64 | 0.12 | 0.12 | 0.18 | 0.21 | 0.13 | 0.13 | 0.11 | 0.09 | 0.10 | 0.12 | 0.12 | ||
| LN | 0.002 | 0.001 | 0.001 | 0.00 | 0.13 | 0.13 | 0.20 | 0.23 | 0.14 | 0.14 | 0.12 | 0.09 | 0.10 | 0.13 | 0.13 | |
| RQ | 0.001 | 0.001 | 0.001 | 0.000 | 0.13 | 0.13 | 0.20 | 0.23 | 0.14 | 0.14 | 0.12 | 0.09 | 0.10 | 0.13 | 0.13 | |
| W3 | 0.015 | 0.015 | 0.014 | 0.015 | 0.015 | 0.21 | 0.44 | 0.43 | 0.21 | 0.23 | 0.22 | 0.13 | 0.15 | 0.15 | 0.15 | |
| Crypto | 0.026 | 0.025 | 0.025 | 0.025 | 0.025 | 0.017 | 0.27 | 0.31 | 0.16 | 0.17 | 0.16 | 0.12 | 0.13 | 0.14 | 0.14 | |
| SER | 0.020 | 0.020 | 0.019 | 0.020 | 0.020 | 0.011 | 0.018 | 0.89 | 0.25 | 0.28 | 0.35 | 0.17 | 0.19 | 0.17 | 0.16 | |
| KNU-11 | 0.022 | 0.022 | 0.022 | 0.023 | 0.022 | 0.014 | 0.020 | 0.005 | 0.28 | 0.29 | 0.39 | 0.20 | 0.22 | 0.18 | 0.18 | |
| CPI+ | 0.029 | 0.029 | 0.029 | 0.029 | 0.029 | 0.021 | 0.026 | 0.017 | 0.019 | 0.18 | 0.12 | 0.14 | 0.14 | 0.14 | ||
| CPI− | 0.030 | 0.030 | 0.029 | 0.030 | 0.030 | 0.022 | 0.027 | 0.017 | 0.020 | 0.001 | 0.19 | 0.13 | 0.14 | 0.14 | 0.14 | |
| 1168-1 | 0.020 | 0.020 | 0.019 | 0.020 | 0.020 | 0.011 | 0.018 | 0.009 | 0.012 | 0.018 | 0.019 | 0.11 | 0.13 | 0.16 | 0.15 | |
| 78524 | 0.027 | 0.027 | 0.026 | 0.027 | 0.027 | 0.020 | 0.025 | 0.017 | 0.020 | 0.026 | 0.027 | 0.013 | 0.28 | 0.14 | 0.13 | |
| H221 | 0.027 | 0.027 | 0.026 | 0.027 | 0.026 | 0.019 | 0.025 | 0.017 | 0.020 | 0.026 | 0.027 | 0.013 | 0.001 | 0.14 | 0.14 | |
| 08-1990 | 0.044 | 0.044 | 0.043 | 0.044 | 0.044 | 0.036 | 0.043 | 0.032 | 0.036 | 0.041 | 0.042 | 0.030 | 0.028 | 0.027 | 0.11 | |
| D277 | 0.045 | 0.044 | 0.044 | 0.045 | 0.045 | 0.037 | 0.043 | 0.033 | 0.036 | 0.042 | 0.042 | 0.030 | 0.028 | 0.028 | 0.003 | |
The bottom left half shows the number of substitutions per nucleotide site. The top right half shows ω values, with high values in boldface type. Crypto, cryptovirus.
FIG 1Maximum likelihood phylogenetic tree derived from an alignment of 16 complete PIV5 genome sequences, rooted at the midpoint. Bootstrap confidence values of >70% (from 100 tests) are indicated. The scale indicates the number of substitutions per site.
FIG 2Nucleotide substitutions per site (π) measured in a 500-nt sliding window along an alignment of 16 complete PIV5 genome sequences. Values are plotted to correspond to the center of the window. The arrangement of ORFs is indicated.
Values of ω and κ in 16 PIV5 genomes for individual ORFs
| ORF | Size (nt) | ω | κ |
|---|---|---|---|
| NP | 1,530 | 0.13 | 11.99 |
| V | 669 | 0.32 | 11.90 |
| P | 1,179 | 0.38 | 9.67 |
| M | 1,134 | 0.15 | 6.64 |
| F | 1,590 | 0.29 | 7.68 |
| SH | 135 | 0.87 | 21.31 |
| HN | 1,698 | 0.24 | 5.71 |
| L | 6,768 | 0.11 | 7.26 |
SNPs in the PIV5 genome sequences determined in this study
| Strain | Position (nt) | Major variant | Minor variant | Minor variant frequency (%) | ORF(s) or region affected | Coding difference(s) |
|---|---|---|---|---|---|---|
| MIL | 71 | a | G | 8 | N 5′ UTR | None |
| 1462 | c | U | 30 | N | None | |
| 1493 | c | U | 31 | N | H448Y | |
| 1511 | U | c | 17 | N | Y454H | |
| 1601 | c | U | 26 | N | None | |
| 1645 | U | c | 26 | N | None | |
| 1715 | U | c | 13 | V/P 5′ UTR | None | |
| 1746 | U | c | 12 | V/P 5′ UTR | None | |
| 1764 | U | c | 12 | V/P 5′ UTR | None | |
| 5544 | C | a | 6 | F | Q339K | |
| 6884 | u | C | 33 | HN | F101L | |
| 6885 | U | c | 10 | HN | F101P | |
| 11799 | A | g | 5 | L | K1129R | |
| 13697 | u | C | 10 | L | Y1762H | |
| DEN | 1471 | A | g | 6 | N | None |
| 1561 | U | c | 2 | N | None | |
| 1650 | U | c | 43 | N | L500P | |
| 1737 | U | c | 8 | N 3′ UTR | None | |
| 3620 | A | g | 42 | M | I160M | |
| 4218 | A | c | 3 | M | N360H | |
| 5840 | A | g | 42 | F | None | |
| 7216 | A | g | 8 | HN | None | |
| 7698 | C | u | 45 | HN | T372I | |
| 9662 | G | u | 24 | L | V417L | |
| 10755 | C | u | 14 | L | T781I | |
| 10837 | A | g | 8 | L | None | |
| 12406 | A | g | 18 | L | None | |
| 12463 | A | c | 6 | L | None | |
| 12491 | U | c | 3 | L | F1360L | |
| 13810 | A | g | 33 | L | None | |
| 14421 | C | u | 25 | L | A2003V | |
| 14723 | A | g | 38 | L | R2104G | |
| 14982 | U | c | 8 | L | L2190S | |
| LN | 5259 | A | g | 5 | F | I244V |
| 6938 | u | C | 42 | HN | None | |
| 14975 | U | c | 2 | L | None | |
| RQ | 14291 | A | g | 8 | L | T1958A |
| 14965 | U | c | 5 | L | None | |
| W3 | 25 | u | C | 47 | Leader | None |
| 4599 | a | G | 25 | F | T24A | |
| 5807 | C | u | 5 | F | None | |
| 5879 | C | u | 15 | F | None | |
| 7702 | U | g | 29 | HN | N373K | |
| 14927 | A | g | 20 | L | N2172D | |
| PIV5VΔCp6 | 25 | u | C | 44 | Leader | None |
| 9356 | C | u | 34 | L | H315Y | |
| 11870 | c | U | 48 | L | None | |
| SER | 570 | C | u | 10 | N | T140I |
| 1227 | g | A | 48 | N | R359K | |
| 4709 | G | c | 12 | F | None | |
| 8201 | A | c | 19 | HN | I540L | |
| 9191 | U | c | 39 | L | Y260H | |
| 9658 | U | a | 9 | L | H415Q | |
| 9995 | G | u | 9 | L | V528L | |
| 10356 | A | g | 3 | L | D648G | |
| 11598 | U | c | 5 | L | I1062T | |
| 14156 | C | U | 11 | L | R1915C | |
| CPI+ | 1520 | G | a | 6 | N | E457K |
| 1891 | U | c | 5 | V, P | None | |
| 1925 | U | c | 6 | V, P | Y26H | |
| 1998 | U | c | 6 | V, P | L50P | |
| 2395 | U | c | 14 | V, P | None, M183T | |
| 2618 | A | g | 4 | P | I257M | |
| 5364 | A | g | 15 | F | T279A | |
| 6708 | A | g | 5 | HN | Q42R | |
| 6878 | A | g | 14 | HN | K99E | |
| 7224 | A | g | 12 | HN | K214R | |
| 8142 | A | g | 8 | HN | E520G | |
| 9105 | C | u | 16 | L | T231I | |
| 9184 | U | c | 11 | L | None | |
| 10135 | U | g | 16 | L | None | |
| 12492 | U | c | 16 | L | F1360S | |
| 12529 | A | c | 8 | L | None | |
| 13390 | C | u | 11 | L | None | |
| 14775 | a | G | 15 | L | D2121G | |
| CPI− | 1435 | U | c | 4 | N | None |
| 6889 | A | c | 11 | HN | Q102H | |
| 7128 | U | a | 6 | HN | L182Q | |
| 7803 | A | c | 26 | HN | N407T | |
| 8141 | G | a | 6 | HN | E520K | |
| 10513 | A | u | 22 | L | None | |
| 11896 | A | g | 5 | L | None | |
| 13318 | U | a | 11 | L | None | |
| 15221 | u | G | 46 | Trailer | None | |
| 78524 | 3382 | G | a | 4 | M | R81K |
| 5620 | G | a | 9 | F | S364N | |
| 5862 | G | a | 10 | F | D445N | |
| 7145 | C | u | 43 | HN | H188Y | |
| 7146 | A | g | 24 | HN | H188R | |
| 7679 | C | u | 11 | HN | P366S | |
| 10765 | A | g | 9 | L | None | |
| 13712 | A | g | 7 | L | N1767D | |
| 13731 | C | u | 15 | L | T1773I | |
| 14159 | G | a | 8 | L | A1916T | |
| 14189 | C | u | 2 | L | P1926S | |
| 14313 | U | g | 10 | L | F1967C | |
| 14355 | C | a | 6 | L | A1981D | |
| 14360 | C | u | 14 | L | H1983Y | |
| 14503 | C | a | 4 | L | H2030Q | |
| 14506 | A | u | 14 | L | L2031F | |
| 14532 | C | u | 4 | L | A2040V | |
| 14993 | U | g | 3 | L | Y2194D | |
| H221 | 2319 | c | U | 4 | V, P | S157F |
| 2765 | a | U | 5 | P | K306N | |
| 4295 | C | a | 5 | M 3′ UTR | None | |
| 7023 | A | c | 4 | HN | N147T | |
| 7058 | a | G | 4 | HN | K159E | |
| 9712 | A | g | 13 | L | None | |
| 10755 | C | u | 3 | L | T781I | |
| 12400 | A | g | 3 | L | None | |
| 13032 | C | a | 13 | L | P1540Q | |
| 13703 | U | g | 5 | L | F1764V | |
| 13874 | u | C | 4 | L | None | |
| 14349 | a | G | 46 | L | D1979G |
No SNPs were detected in strain MEL.
In the genome sequence of the relevant strain.
The original nucleotide inferred from the alignment of PIV5 genome sequences is shown in uppercase type, and the mutant nucleotide is shown in lowercase type. In the single instance where an inference could not be made (nt 14156 in strain SER), both nucleotides are shown in uppercase type.
The amino acid residue in the major population is shown to the left of the position in the relevant protein, and that in the minor population is shown to the right. Note that the original nucleotide may correspond to the major or minor population (see above).
The minor variant at nt 6885 is linked to that at nt 6884.
The four clustered SNPs associated with pseudoreversion in the V ORF are not listed and are instead described in the text.
FIG 3Effects of variation in the PIV5 SH gene on expression of SH. (a) Alignment of genome sequences (in the antigenome or mRNA sense) in the region at nt 6264 to 6473. The line divides primate strains (top) from nonprimate strains (bottom). U-to-C transitions, other transitions, and transversions are shaded black, light gray, and dark gray, respectively, generally for nonprimate strains in relation to primate strains. The amino acid sequence of strain W3 SH is also shown, with the peptide against which the SH antibody was used in panel b shaded light gray. (b) Immunoblot of mock-infected cells (M) and cells infected with PIV5 strains W3, CPI+, CPI−, and SER, probed with antibodies against PIV5 SH, PIV5 P, and cellular actin.
SNPs during passage of PIV5 strain W3
| Position (nt) | Major variant | Minor variant | ORF(s) or region affected | Coding difference(s) | Kinetics | Minor variant frequency (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| W3vM0 | W3vM8 | W3vM9 | W3vM10 | W3vM11 | W3vM12 | ||||||
| 14 | U | c | Leader | None | I | 0.00 | 93.88 | 97.43 | 97.67 | 99.51 | 98.28 |
| 25 | u | C | Leader | None | D | 47.03 | 0.00 | 0.44 | 0.33 | 0.21 | 0.43 |
| 2482 | U | c | V, P | None, V212A | I | 0.11 | 4.45 | 7.89 | 13.45 | 16.37 | 19.35 |
| 4599 | a | G | F | T24A | D | 24.77 | 0.18 | 0.44 | 0.15 | 0.31 | 0.29 |
| 5807 | C | u | F | None | D | 5.28 | 0.03 | 0.00 | 0.00 | 0.04 | 0.00 |
| 5879 | C | u | F | None | D | 14.91 | 0.03 | 0.00 | 0.07 | 0.04 | 0.09 |
| 7702 | U | g | HN | N373K | D | 29.35 | 2.78 | 2.21 | 1.50 | 1.09 | 0.74 |
| 10442 | A | c | L | I677L | I | 0.03 | 4.91 | 5.85 | 7.76 | 8.75 | 9.84 |
| 11967 | C | a | L | A1185D | I | 0.03 | 4.64 | 6.83 | 7.99 | 9.36 | 8.51 |
| 13261 | A | c | L | L1616F | I | 0.02 | 3.67 | 7.41 | 12.28 | 13.91 | 13.46 |
| 14927 | A | g | L | N2172D | D | 19.64 | 12.87 | 10.53 | 12.46 | 7.96 | 5.31 |
The original nucleotide inferred from the PIV5 genome alignment is shown in uppercase type, and the mutant nucleotide is shown in lowercase type.
The amino acid residue in the major population is shown to the left of the position in the relevant protein, and that in the minor population is shown to the right. Note that the original nucleotide may correspond to the major or minor population.
I, increasing in proportion during passage; D, decreasing in proportion during passage.
The numbers of reads obtained (with the proportions that aligned to the strain W3 genome sequence in parentheses) were as follows: W3vM0, 21,156,178 (78%); W3vM8, 3,233,587 (59%); W3vM9, 3,210,385 (30%); W3vM10, 3,473,827 (42%); W3vM11, 3,636,000 (51%); W3vM12, 3,789,267 (37%).
FIG 4Variation in a region of the PIV5 V/P gene after passaging of PIV5VΔC 6 times in Vero cells to generate PIV5VΔCp6. The number of reads that aligned to the complete PIV5VΔC genome sequence was 22,456,971 (71% of the total). (a) The RNA sequence in W3 and its translation as part of P and V, with coordinates in the genome or amino acid sequences on the right. (b) The RNA sequence in PIV5VΔC and its translation, with substitutions shaded gray and introduced termination codons in the V gene heavily underlined. The light underlining indicates the flanking sequences that were utilized to isolate reads for analysis of SNPs. (c) The four substitutions (sub1 to sub4) detected in this region of PIV5VΔCp6. (d to h) The five major sequence constellations of sub1 to sub4 (parental PIV5VΔC, sub13, sub134, sub123, and sub1234), with percentages of reads on the right. Nucleotide and amino acid substitutions, in comparison with PIV5VΔC, are shaded gray.